Ad5 [E1-, E2b-]-Brachyury 5. Ad5 [E1-, E2b-]- MUC1 6. GI-4014 expressing mutations in RAS at codon 12 (G12V), and codon 61 (Q61R and Q61L); GI-4015 expressing mutations in RAS at codon 12 (G12C), and codon 61 (Q61R and Q61L); GI-4016 expressing mutations in RAS at codon 12 (G12D) and codon 61 (Q61R and Q61L); and GI-4020 expressing mutations in RAS at codon 12 (G12R) and codon 61 (Q61L and Q61H) 7. Recombinant yeast -based vacci ne expressing the full length human carcinoembryonic antigen (CEA), with a modified gene coding sequence to code for a single amino acid substitution (asparagine to aspartic acid) at the native protein amino acid position 610 8. Recombinant yeast -based vaccin e expressing the human Brachyury oncoprotein 9. NK-92 [CD16.158V, ER IL2] cells Approved Products: 10. Avelumab 11. Bevacizumab 12. Capecitabine 13. Cisplatin 14. Cyclophosphamide (anhydrous) 15. Fluorouracil, USP 16. Leucovorin (calcium salt) 17.